definiens: means, with respect to a Profit - Share Product, ro yalties, license fees or other payments, as applicable, that are made to any Third Party for the use of any Thi rd Party Technology and are reasonably allocable to and reas onably necessary or useful for, the Development, Manufacturing or Commercialization of such Licensed Product in the Field in the Territory . For the avo idance of doubt : ( a ) the amounts payable to the KHK Licenso rs under the KHK In - Licenses are Third Party Technology Costs, provided however that : ( i ) with respect to payments paid by KHK t o LJI * * * * *, only payments stipulated in paragraphs ( 1 ) and ( 3 ) of Section 12 of such add endum will be included in the Third Party Technolog y Costs and all other costs such as milestone payments will be solely borne by KHK and not included in Third P arty Technology Costs ; ( ii ) with respect to payments paid by KHK t o Lonza * * * * *, only payments stipulated in Section 5.2 of such agreement will be included in the Third Party Technology Costs and a ll other costs except for annual maintenance fee which is st ipulated in Section 8.6.4(c ) in this Agreement, wil l be solely borne by KHK and not included in Third Party Techno logy Costs ; ( iii ) with respect to payments paid by KHK t o BMS * * * * *, only payments stipulated in Section 10.6.1(a)(i ) of such agreemen t will be included in the Third Party Technology Co sts and all other costs will be solely borne by KHK and not inc luded in Third Party Technology Costs ; ( b ) the amounts payable by [COMPANY] : ( i ) to the [COMPANY] Licensor pursuant to Section 6.4.1 and, with respect to amounts payable after receipt of the first Regulato ry Approval for a Licensed Product in the Field in the Territory or the European Union, pursuant to Section 6.2 unde r the [COMPANY] In - License will be included in the Third Party Technology Costs, and payments paid by [COMPANY] to CHOP with respect of all other costs under the Med genics In - License, including but not limited to milestone payments, will be solely borne by [COMPANY] and not included in Third Party Technology Costs ; and * * * * * Confidential Information has been omitted and file d separately with the Securities and Exchange Commission . Confidential treatment has been request ed with respect to this omitted information